Drug Trial Radar · NCT06879782
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
Last checked: Nov 20, 2026Latest source record: Mar 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
820
Planned (sponsor's estimate)
Start
Mar 28, 2024
Primary completion
Mar 28, 2026
Study completion Sep 28, 2026
Sponsor
- Lead sponsor
- Lunan Better Pharmaceutical Co., LTD.Industry
- Sponsor type
- Industry
- Collaborators
- Beijing Tongren Hospital
- First posted
- Mar 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of Lifitegrast Ophthalmic Solution.
Conditions
- Dry Eye Disease (DED)
Interventions
Drug placeboDrug
Instill one drop of the eye solution in each eye, twice a day (morning and evening, approximately 12 hours apart), for a treatment period of 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Inferior Corneal Fluorescein Staining ScoreTime frame: After 84 days of treatment
- Eye Dryness ScoreTime frame: After 84 days of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.